| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| PROVECTUS BIOPHARMACEUTICALS, INC. | President, Director | Stock Options (Right to Buy) | 16,146,600 | 02 Dec 2024 | Direct | ||
| PROVECTUS BIOPHARMACEUTICALS, INC. | President, Director | Series D-1 Convertible Preferred Stock | 1,337,876 | 30 Sep 2024 | Direct | ||
| PROVECTUS BIOPHARMACEUTICALS, INC. | President, Director | Series D Convertible Preferred Stock | 0 | 25 Jun 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| PVCT | PROVECTUS BIOPHARMACEUTICALS, INC. | 02 Dec 2024 | 1 | $0 | 4 | President, Director | 04 Dec 2024, 19:52 |
| PVCT | PROVECTUS BIOPHARMACEUTICALS, INC. | 30 Sep 2024 | 1 | $0 | 4 | PRESIDENT, Director | 30 Sep 2024, 18:58 |
| PVCT | PROVECTUS BIOPHARMACEUTICALS, INC. | 25 Jun 2024 | 2 | $0 | 4 | PRESIDENT, Director | 23 Jul 2024, 17:20 |
| PVCT | PROVECTUS BIOPHARMACEUTICALS, INC. | 16 Sep 2022 | 1 | +$3,267,334 | 4 | Director | 20 Sep 2022, 17:26 |